Synergistic Tissue Ablation Systems using AI, IoT, and Novel Materials

Publication ID: 24-11857244_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Tissue Ablation Systems using AI, IoT, and Novel Materials,” Published Technical Disclosure No. 24-11857244_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857244_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,244.

Summary of the Inventive Concept

The inventive concept integrates AI-driven pulse shape design, IoT-enabled ablation devices, and novel materials with enhanced electro-osmotic diffusion properties to create a more powerful and efficient tissue ablation system, offering improved treatment outcomes and reduced complications.

Background and Problem Solved

The original patent disclosed methods, systems, and apparatuses for tissue ablation using pulse shape designs. However, these approaches have limitations, such as the need for manual optimization of pulse shape designs and the potential for electric discharge of gases during treatment. The new inventive concept addresses these limitations by incorporating AI-driven optimization, IoT-enabled real-time monitoring, and novel materials to create a more synergistic and effective tissue ablation system.

Detailed Description of the Inventive Concept

The inventive concept comprises an AI-driven pulse shape design module that integrates with an IoT-enabled ablation device. The AI module optimizes pulse shape designs for synergistic electroporation and electrolysis effects, reducing the need for manual optimization. The IoT-enabled device enables real-time monitoring and data exchange between the device and a cloud-based server, facilitating personalized treatment planning and adaptive tissue ablation. Additionally, the incorporation of novel materials with enhanced electro-osmotic diffusion properties further enhances the system's efficiency and effectiveness. The system can be used for various tissue ablation applications, including cancer treatment and cosmetic procedures.

Novelty and Inventive Step

The new claims introduce the novel combination of AI-driven pulse shape design, IoT-enabled ablation devices, and novel materials, which provides a synergistic effect that is not obvious from the original patent. The integration of these distinct technologies enables a more powerful and efficient tissue ablation system that was not anticipated by the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of blockchain-secured data storage for enhanced data security, or the incorporation of other novel materials with different properties. Variations of the system may be designed for specific tissue ablation applications, such as cardiac ablation or ophthalmic treatments.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cancer treatment, cosmetic procedures, and minimally invasive surgeries. The system's ability to provide improved treatment outcomes and reduced complications makes it an attractive solution for hospitals, clinics, and medical research institutions.

CPC Classifications

SectionClassGroup
A A61 A61B18/1206
A A61 A61B18/1402
A A61 A61N1/205
A A61 A61N1/327
A A61 A61B5/14539
A A61 A61B2018/00577
A A61 A61B2018/00613
A A61 A61B2018/00827
A A61 A61B2018/00994
A A61 A61B2018/1266
A A61 A61B2018/1472

Original Patent Information

Patent NumberUS 11,857,244
TitleMethods, systems, and apparatuses for tissue ablation using pulse shape designs
Assignee(s)RM2 TECHNOLOGY LLC, Inter Science GmbH